申请人:Bayer Aktiengesellschaft
公开号:US05962513A1
公开(公告)日:1999-10-05
Diseases characterized by disturbances of the serotoninergic system, psychoses and depression are treated by administration of an aminomethyl-chroman of the formula ##STR1##
以
氨甲基
色酮的方式治疗由5-羟
色胺系统紊乱、精神病和抑郁症所表现的疾病,该
氨甲基
色酮的
化学式为##STR1##